指南与共识复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

拯救脓毒症运动:COVID-19 重症成人管理指南

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).
指南 / 共识 · Intensive Care Med · 2020-03-28
一句话结论拯救脓毒症运动专家组基于 GRADE 就 COVID-19 重症成人感染控制、诊断、血流动力学、通气和治疗给出 54 条声明(9 条强推荐、35 条弱推荐、4 条最佳实践声明)。

该指南由 36 名来自 12 个国家的专家组成小组,围绕 ICU 内 COVID-19 危重患者管理的 53 个问题检索直接与间接证据,采用 GRADE 方法评估证据确定性,并结合获益与危害、资源与成本、公平性和可行性生成推荐。最终发布 54 条声明,包括 4 条最佳实践声明、9 条强推荐和 35 条弱推荐,6 个问题未给出推荐。主题覆盖感染控制、实验室诊断与标本、血流动力学支持、通气支持和 COVID-19 治疗五个方面。

要点

  • 专家组来自 12 个国家共 36 人,围绕 ICU 内 COVID-19 危重患者管理的 53 个问题制定推荐。
  • 共发布 54 条声明:4 条最佳实践声明、9 条强推荐、35 条弱推荐;6 个问题未给出推荐。
  • 证据确定性采用 GRADE 方法评估,推荐基于获益与危害、资源与成本、公平性和可行性的平衡。
  • 推荐主题覆盖感染控制、实验室诊断与标本、血流动力学支持、通气支持和 COVID-19 治疗。
  • 指南拟在后续版本中,在有新证据可用时提供新的推荐。

适用人群与场景

  • ICU 内 COVID-19 危重成人患者。

研究设计与关键结果

  • 制定方法:由 36 名来自 12 个国家的专家组成小组,全体成员完成世界卫生组织利益冲突声明表,提出 53 个与 ICU 内 COVID-19 管理相关的问题,检索直接与间接证据,并对多数支持治疗问题识别相关近期系统评价。
  • 采用 GRADE 方法评估证据确定性,基于获益与危害、资源与成本、公平性和可行性的平衡生成推荐,推荐形式为强推荐、弱推荐或最佳实践声明。
  • 共发布 54 条声明:4 条最佳实践声明、9 条强推荐、35 条弱推荐;6 个问题未给出推荐。
  • 主题涵盖:(1)感染控制,(2)实验室诊断与标本,(3)血流动力学支持,(4)通气支持,(5)COVID-19 治疗。

证据类型、等级与局限

  • 证据类型:指南(拯救脓毒症运动 COVID-19 指南),采用 GRADE 方法评估证据确定性并生成推荐。
  • 推荐强度标签:强推荐、弱推荐、最佳实践声明。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该指南为 ICU 内 COVID-19 危重成人管理提供 54 条声明,覆盖感染控制、实验室诊断与标本、血流动力学支持、通气支持和 COVID-19 治疗五个方面。
  • 6 个问题未给出推荐,提示在这些问题上原文未形成推荐意见。

指南或共识出处

  • 指南名称:Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19);发布机构:拯救脓毒症运动(Surviving Sepsis Campaign);发表期刊:Intensive Care Med。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting thousands of people around the world. Urgent guidance for clinicians caring for the sickest of these patients is needed.

METHODS: We formed a panel of 36 experts from 12 countries. All panel members completed the World Health Organization conflict of interest disclosure form. The panel proposed 53 questions that are relevant to the management of COVID-19 in the ICU. We searched the literature for direct and indirect evidence on the management of COVID-19 in critically ill patients in the ICU. We identified relevant and recent systematic reviews on most questions relating to supportive care. We assessed the certainty in the evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, then generated recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. Recommendations were either strong or weak, or in the form of best practice recommendations.

RESULTS: The Surviving Sepsis Campaign COVID-19 panel issued 54 statements, of which 4 are best practice statements, 9 are strong recommendations, and 35 are weak recommendations. No recommendation was provided for 6 questions. The topics were: (1) infection control, (2) laboratory diagnosis and specimens, (3) hemodynamic support, (4) ventilatory support, and (5) COVID-19 therapy.

CONCLUSION: The Surviving Sepsis Campaign COVID-19 panel issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19. When available, we will provide new recommendations in further releases of these guidelines.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020. PMID: 32222812. doi:10.1007/s00134-020-06022-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。